Israel Chemicals Ltd (NYSE:ICL) – Stock analysts at Jefferies Financial Group lowered their Q3 2018 earnings per share (EPS) estimates for Israel Chemicals in a report released on Tuesday, October 16th, Zacks Investment Research reports. Jefferies Financial Group analyst L. Alexander now expects that the basic materials company will earn $0.08 per share for the quarter, down from their previous estimate of $0.11. Jefferies Financial Group has a “Hold” rating and a $6.57 price objective on the stock. Jefferies Financial Group also issued estimates for Israel Chemicals’ Q4 2018 earnings at $0.09 EPS, FY2018 earnings at $0.35 EPS, FY2019 earnings at $0.35 EPS and FY2020 earnings at $0.40 EPS.
Israel Chemicals (NYSE:ICL) last posted its quarterly earnings results on Thursday, November 1st. The basic materials company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. The firm had revenue of $1.37 billion for the quarter, compared to analyst estimates of $1.38 billion. Israel Chemicals had a net margin of 23.84% and a return on equity of 13.67%. Israel Chemicals’s quarterly revenue was down 4.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.09 earnings per share.
NYSE:ICL traded down $0.04 on Wednesday, hitting $6.44. The stock had a trading volume of 224,621 shares, compared to its average volume of 224,791. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.34 and a quick ratio of 0.73. The firm has a market capitalization of $8.26 billion, a price-to-earnings ratio of 20.77, a PEG ratio of 1.88 and a beta of 1.07. Israel Chemicals has a 1-year low of $3.85 and a 1-year high of $6.90.
Several hedge funds have recently modified their holdings of ICL. Lourd Capital LLC purchased a new stake in Israel Chemicals during the 3rd quarter worth approximately $167,000. AXA purchased a new stake in Israel Chemicals during the 3rd quarter worth approximately $181,000. Janus Henderson Group PLC purchased a new stake in Israel Chemicals during the 3rd quarter worth approximately $201,000. Stifel Financial Corp increased its stake in Israel Chemicals by 276.8% during the 1st quarter. Stifel Financial Corp now owns 45,338 shares of the basic materials company’s stock worth $185,000 after buying an additional 33,305 shares during the period. Finally, Eqis Capital Management Inc. purchased a new stake in Israel Chemicals during the 2nd quarter worth approximately $245,000. Hedge funds and other institutional investors own 8.10% of the company’s stock.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 19th. Stockholders of record on Tuesday, December 4th will be issued a $0.051 dividend. This is a positive change from Israel Chemicals’s previous quarterly dividend of $0.04. This represents a $0.20 annualized dividend and a dividend yield of 3.17%. The ex-dividend date of this dividend is Monday, December 3rd. Israel Chemicals’s dividend payout ratio is currently 32.26%.
Israel Chemicals Company Profile
Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash, salt, and Polysulphate; and produces, markets, and sells pure magnesium and magnesium alloys, as well as produces dry carnallite and related by-products, including chlorine and sylvinite.
Recommended Story: What is a Tariff?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.